Shuttle Pharmaceuticals ... (SHPH)
0.82
-0.06 (-6.29%)
At close: Jan 28, 2025, 12:34 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY18 | FY17 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 6.81K | 66.83K | 60.83K | 54.95K | 18.00K | 18.74K |
| Gross Profit | -6.81K | -66.83K | -60.83K | -54.95K | -18.00K | -18.74K |
| Operating Income | -5.89M | -2.55M | -1.74M | -509.52K | -586.63K | -203.89K |
| Interest Income | 79.12K | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -6.59M | -3.03M | -1.15M | -805.73K | -626.14K | -213.59K |
| Net Income | -6.59M | -3.10M | -1.20M | -845.36K | -626.14K | -213.59K |
| Selling & General & Admin | 1.05M | 1.07M | 721.18K | 347.75K | 513.06K | 185.99K |
| Research & Development | 3.52M | 1.49M | 1.02M | 161.77K | 55.57K | -836 |
| Other Expenses | 1.33M | 328.69K | n/a | n/a | n/a | n/a |
| Operating Expenses | 5.89M | 2.55M | 1.74M | 509.52K | 568.63K | 185.15K |
| Interest Expense | 2.60M | 969.89K | 50.79K | 39.63K | 30.92K | 10.88K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 5.89M | 2.55M | 1.74M | 509.52K | 586.63K | 203.89K |
| Income Tax | n/a | 71.01K | 50.79K | 39.63K | n/a | 1.00 |
| Shares Outstanding (Basic) | 15.91M | 10.35M | 13.59M | 13.59M | 13.59M | 13.59M |
| Shares Outstanding (Diluted) | 15.91M | 10.35M | 13.59M | 13.59M | 13.59M | 13.59M |
| EPS (Basic) | -0.41 | -0.3 | -0.09 | -0.06 | -0.05 | -0.02 |
| EPS (Diluted) | -0.41 | -0.3 | -0.09 | -0.06 | -0.05 | -0.02 |
| EBITDA | -3.99M | -4.32M | -1.04M | -711.15K | -577.22K | -183.97K |
| Depreciation & Amortization | 6.81K | 5.97K | 60.83K | 54.95K | 18.00K | 18.74K |